Show simple item record

Home Study Course: Spring 2001

dc.contributor.authorSpitzer, Marken_US
dc.contributor.authorHaefner, Hope K.en_US
dc.contributor.authorElta, Grace H.en_US
dc.date.accessioned2010-06-01T19:13:29Z
dc.date.available2010-06-01T19:13:29Z
dc.date.issued2001-04en_US
dc.identifier.citationSpitzer, Mark; Haefner, Hope K.; Elta, Grace H. (2001). "Home Study Course: Spring 2001." Journal of Lower Genital Tract Disease 5(2): 105-108. <http://hdl.handle.net/2027.42/72408>en_US
dc.identifier.issn1089-2591en_US
dc.identifier.issn1526-0976en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72408
dc.format.extent7486276 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Science Incen_US
dc.rightsAmerican Society for Colposcopy and Cervical Pathologyen_US
dc.titleHome Study Course: Spring 2001en_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Internal Medicine, The University of Michigan Hospitals, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherDepartment of Obstetrics and Gynecology, New York University, and North Shore University Hospital, Manhasset, NYen_US
dc.contributor.affiliationother* Department of Obstetrics and Gynecology, anden_US
dc.identifier.pmid17043586en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72408/1/j.1526-0976.2001.005002105.x.pdf
dc.identifier.doi10.1046/j.1526-0976.2001.005002105.xen_US
dc.identifier.sourceJournal of Lower Genital Tract Diseaseen_US
dc.identifier.citedreferenceClemett D & Markham A. Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease. Drugs 2000; 59: 929 – 56.en_US
dc.identifier.citedreferenceHanauer SB. Updating the approach to Crohn's disease. Hospital Practice (Office Edition) 1999; 34: 77 – 8, 81–3, 87–93; discussion 94.en_US
dc.identifier.citedreferenceHoffmann JC & Zeitz M. Treatment of Crohn's disease. Hepato-Gastroenterology 2000; 47: 90 – 100.en_US
dc.identifier.citedreferenceMcKinney A, Wallace JA, Alderdice JM. Crohn's disease of the labia minora. Ulster Med J 1995; 64: 92 – 4.en_US
dc.identifier.citedreferencePresent DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. New Engl J Med 1999; 340: 1398 – 405.en_US
dc.identifier.citedreferenceRaza A. Anti-TNF therapies in rheumatoid arthritis, Crohn's disease, sepsis, and myelodysplastic syndromes. Microscopy Res Technique 2000; 50: 229 – 35.en_US
dc.identifier.citedreferenceRegimbeau JM, Panis Y, Marteau P, Benoist S, Valleur P. Surgical treatment of anoperineal Crohn's disease: can abdominoperineal resection be predicted? J Amer Coll Surgeons 1999; 189: 171 – 6.en_US
dc.identifier.citedreferenceRutgeerts P & Baert F. Immunosuppressive drugs in the treatment of Crohn's disease. Euro J Surg 1998; 164: 911 – 5.en_US
dc.identifier.citedreference9. Sandborn W, Sutherland L, Pearson D, May G, Modi- gliani R, Prantera C. Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease. Cochrane Database of Systematic Reviews [computer file]. (2):CD000545, 2000. 20257647.en_US
dc.identifier.citedreference10. Steinhart AH, Ewe K, Griffiths AM, Modigliani R, Thomsen OO. Corticosteroids for maintaining remission of Crohn's disease. Cochrane Database of Systematic Reviews [computer file]. (2):CD000301, 2000. 20257615.en_US
dc.identifier.citedreferenceUrbanek M, Neill SM, McKee PH. Vulvar Crohn's disease: difficulties in diagnosis. Clin Experim Dermat 1996; 21: 211 –  4.en_US
dc.identifier.citedreferenceVettraino IM & Merritt DF. Crohn's disease of the vulva. Amer JDermatopathol 1995; 17: 410 – 3.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.